U.S. Other Utilities Stock News

NYSE:SO
NYSE:SOElectric Utilities

Assessing Southern (SO) Valuation After Earnings And Revenue Surprises Fuel Share Price Momentum

Southern (SO) is back in focus after reporting earnings and revenue that came in ahead of analyst expectations. Both metrics showed positive surprises that helped fuel the recent share price move. See our latest analysis for Southern. The latest move takes Southern’s share price to $94.95, with a 1-day share price return of 2.58%, a 7-day share price return of 5.41% and a 30-day share price return of 6.81%. The 1-year total shareholder return of 14.66% and 5-year total shareholder return of...
NYSE:DVA
NYSE:DVAHealthcare

Why DaVita (DVA) Is Up 5.8% After Massive Buybacks Amid Softer Earnings - And What's Next

In early February 2026, DaVita Inc. reported fourth‑quarter 2025 revenue of US$3,619.79 million and full‑year 2025 revenue of US$13.64 billion, alongside a year-on-year decline in net income and earnings per share. Over the same period, DaVita completed very large share repurchase programs totaling more than US$7.45 billion since 2020, significantly shrinking its share count and underscoring management’s commitment to capital returns while it advances integrated, value-based kidney...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Is Bentley Systems (BSY) Pricing Reflect Recent Volatility And Infrastructure Software Growth Prospects

This article walks through the numbers so you can consider whether Bentley Systems' current share price reflects what the business is worth. At a last close of US$34.10, the stock has returned 2.8% over the past week. The 30 day, year to date, 1 year and 3 year returns of 12.9%, 10.6%, 27.4% and 15.4% respectively indicate that recent trading has not moved in a straight line. Recent coverage has focused on Bentley Systems' role in infrastructure and engineering software, including ongoing...
NYSE:HXL
NYSE:HXLAerospace & Defense

How Investors Are Reacting To Hexcel (HXL) Upgrade On Improving Widebody Demand And Composite Focus

Bank of America Securities recently upgraded Hexcel from Underperform to Neutral, citing an improved outlook for widebody aircraft production and stronger demand for the company’s advanced composites from major manufacturers such as Airbus and Boeing. This shift in analyst sentiment, alongside Hexcel’s tighter focus on core carbon fiber capabilities and long-term aerospace relationships, highlights how industry recovery and portfolio refinement are reshaping expectations for the...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

How Roku’s First Profitable Year and Platform Momentum Could Impact Roku (ROKU) Investors

In February 2026, Roku reported fourth-quarter 2025 revenue of US$1,394.9 million and net income of US$80.48 million, capping its first full year of profitability with full-year revenue of US$4,737.25 million and net income of US$88.36 million. The results were fueled by accelerating, higher-margin platform revenue, outperformance in video advertising, and record premium subscription additions, while Roku outlined plans for bundled subscriptions, AI-enhanced ad tools, and further margin...
NasdaqGS:SAIC
NasdaqGS:SAICProfessional Services

Why Science Applications International (SAIC) Is Down 11.9% After Cutting Fiscal 2027 Revenue Guidance

In early February 2026, Science Applications International Corporation updated its outlook, cutting expected fiscal 2027 revenue to between US$7.0 billion and US$7.20 billion from US$7.35 billion to US$7.55 billion, and signaled an organic revenue decline tied to procurement delays and unfavorable recompete outcomes. Management also outlined a shift toward more selective, technology‑focused bids and mission and engineering work, indicating a meaningful recalibration of how the company...
NYSE:FBIN
NYSE:FBINBuilding

Fortune Brands CEO Shift Puts Cost Cuts And Margins In Focus

Fortune Brands Innovations (NYSE:FBIN) appointed longtime board member and consumer products executive Amit Banati as CEO, effective May 2026. Banati will succeed Nicholas Fink, whose departure sets up a planned transition period for the company. Board chair Susan Kilsby will take on interim leadership responsibilities during the handover. The leadership change comes while the company is working through operational restructuring, margin pressures, and cost-saving efforts. For investors, the...
NYSE:JXN
NYSE:JXNDiversified Financial

TPG’s US$500 Million Partnership Could Be A Game Changer For Jackson Financial (JXN)

On February 11, 2026, TPG Inc. completed a long-term partnership with Jackson Financial Inc., including a US$500,000,000 common equity investment for roughly 6.5% of the company and a 10-year renewable investment management agreement. This deal meaningfully reshapes Jackson’s business mix by adding external asset-based finance and direct lending expertise to support its spread-focused annuity platform. Now we’ll examine how TPG’s US$500,000,000 equity infusion and investment management role...
NYSE:DOLE
NYSE:DOLEFood

A Look At Dole (DOLE) Valuation After Its Award Winning Colada Royale Pineapple Launch

Why Dole’s award winning pineapple matters for stock watchers Dole (DOLE) just picked up a 2026 Best New Product Award for its Colada Royale Pineapple, a variety developed over 15 years. The recognition is putting fresh attention on how product launches might influence the stock. See our latest analysis for Dole. The award comes as the share price sits at US$15.91 and recent momentum has been positive, with an 8.7% 30 day share price return and a 13.3% 90 day share price return. The 1 year...
NYSE:MH
NYSE:MHConsumer Services

Is McGraw Hill (MH) Pricing Reflect Its Recent Share Price Weakness And Cash Flow Outlook

If you are asking yourself whether McGraw Hill is priced attractively right now, this article will walk through what the current share price might be implying about the business. The stock last closed at US$13.67, with a recent 7 day return of 8.3%, a 30 day return of 5.7% decline, and a year to date return of 16.4% decline, which may have caught your eye if you are watching for changing risk and reward. Recent evergreen coverage interest around McGraw Hill has focused on how the market is...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Exact Sciences (EXAS) Loss Rebound In Q4 Challenges Profitability Progress Narrative

Exact Sciences (EXAS) just reported its FY 2025 numbers with fourth quarter revenue of US$878.4 million, a basic EPS loss of US$0.45 and net income loss of US$86.0 million, while on a trailing twelve month basis revenue came in at about US$3.2 billion with a basic EPS loss of US$1.10 and a net income loss of US$207.9 million. The company has seen quarterly revenue move from US$713.4 million in Q4 2024 to US$878.4 million in Q4 2025, with basic EPS losses over that span ranging from US$4.67 to...
NYSE:NATL
NYSE:NATLDiversified Financial

Assessing NCR Atleos (NATL) Valuation After AI Award For Intelligent Diagnostics Platform

NCR Atleos award puts AI driven ATM capabilities in focus NCR Atleos (NATL) recently received the ATM Industry Association's Peter Kulik Innovation Award for its Intelligent Diagnostics platform, an AI based system that targets more accurate and efficient ATM service resolution. See our latest analysis for NCR Atleos. The award comes as NCR Atleos shares trade at $42.24, with recent AI driven product news and contract renewals, such as the Heart of England Co operative deal, coinciding with a...
NYSE:NEU
NYSE:NEUChemicals

NewMarket Balances Specialty Materials Growth With Petroleum Additives Headwinds

NewMarket (NYSE:NEU) is seeing strong momentum in its Specialty Materials segment, helped by the acquisition of Calca Solutions and higher volumes at AMPAC. The company is contending with softer conditions and inflation pressures in its core Petroleum Additives business. NewMarket is putting capital into technology and capacity expansion while also returning substantial cash to shareholders. NewMarket, trading at about $592.8, has delivered a 67.3% return over 5 years and 82.1% over 3...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate

Illumina (NasdaqGS:ILMN) has partnered with the San Diego Zoo Wildlife Alliance to sequence and analyze thousands of endangered animal genomes. The collaboration centers on the world's largest biobank for endangered species, with the aim of supporting global wildlife conservation efforts. The project is expected to enable broad access to genomic data for conservation scientists and biodiversity managers. For investors watching Illumina, this move highlights how its sequencing platforms and...
NYSE:WCN
NYSE:WCNCommercial Services

A Look At Waste Connections (WCN) Valuation After Earnings Beat And 2026 Guidance Update

Waste Connections (WCN) has drawn fresh attention after reporting fourth quarter and full year 2025 results that exceeded Wall Street expectations, along with margin expansion, active acquisitions, capital returns, and cautiously positive 2026 guidance. See our latest analysis for Waste Connections. Despite the upbeat earnings, buybacks and a confirmed quarterly dividend, the share price at US$160.26 reflects recent pressure. The 30 day share price return shows a decline of 4.1% and the 1...
NYSE:YETI
NYSE:YETILeisure

How Slowing Cash Generation Shapes YETI’s (YETI) Long-Term Brand Power and Investment Profile

In recent months, YETI Holdings reported solid quarterly results, but analysts highlighted that its long-term revenue growth has lagged sector expectations and that projections indicate weaker free cash flow margins and a lower return on invested capital ahead. This combination of resilient near-term performance with signs of pressure on future profitability has drawn attention to how effectively YETI can convert its strong brand into sustained, high-quality cash generation. We’ll now...
NasdaqGS:SANA
NasdaqGS:SANABiotechs

Assessing Sana Biotechnology (SANA) Valuation As Analyst Downgrade And FDA Scrutiny Weigh On Sentiment

Why sentiment has turned cautious on Sana Biotechnology (SANA) Sana Biotechnology (SANA) has come under pressure after a recent analyst downgrade, just as the FDA increases regulatory scrutiny on gene therapies, putting extra focus on the company’s upcoming quarterly results and cash position. See our latest analysis for Sana Biotechnology. At a share price of US$3.85, Sana’s recent 30 day share price return of 15.94% and year to date share price return of 8.11% contrast with a 1 year total...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Is It Time To Reconsider Berkshire Hathaway (BRK.A) After Its Strong Multi Year Run

If you are wondering whether Berkshire Hathaway's current share price still makes sense for long term investors, you are not alone. That is exactly what this article will focus on. The stock most recently closed at US$751,424.99, with returns of 1.4% over 30 days, 1.0% year to date, 4.5% over 1 year, 60.8% over 3 years and 106.2% over 5 years. These figures raise fair questions about how its current price lines up with underlying value. Recent headlines have continued to highlight...
NYSE:TSN
NYSE:TSNFood

How Tyson’s New Bond Deal and Dividend Amid Beef Strains At Tyson Foods (TSN) Has Changed Its Investment Story

In early February 2026, Tyson Foods completed a US$498.17 million fixed-rate senior unsecured bond offering and confirmed its quarterly dividend, following first-quarter 2026 results that showed higher sales of US$14,313 million but lower net income of US$85 million versus a year earlier. These moves came as Tyson’s beef operations continued to struggle with very large beef price increases and historically tight US cattle supplies, putting sustained pressure on profitability. Now we’ll...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

Sabra Health Care REIT Shifts CIO As Senior Housing Growth Accelerates

Sabra Health Care REIT (NasdaqGS:SBRA) has appointed Darrin Smith as Chief Investment Officer, Secretary, and Executive Vice President following the retirement of Talya Nevo-Hacohen. The company reports strong operational execution, with gains in occupancy, NOI, and margin within its senior housing portfolio. Sabra highlights an investment pipeline for 2026 that it expects to exceed already high 2025 levels. Sabra Health Care REIT, trading at around $20.17, enters this management transition...
NYSE:DEC
NYSE:DECOil and Gas

Is Diversified Energy (DEC) Share Price Slide Creating A Long Term Opportunity?

If you are wondering whether Diversified Energy's current share price lines up with its underlying worth, you are not alone. This article aims to unpack exactly that. The stock most recently closed at US$13.21, with returns of a 1% decline over 7 days, 5.9% over 30 days, a 10.7% decline year to date and a 16.9% decline over 1 year. This extends to a 40.9% decline over 3 years and a 58.7% decline over 5 years. Recent coverage around Diversified Energy has focused on how investors interpret...
NYSE:SON
NYSE:SONPackaging

How Sonoco’s Renewable Power Deal and Dividend Milestone Will Impact Sonoco Products (SON) Investors

In recent weeks, Sonoco Products Company appointed First Citizens BancShares CFO Craig L. Nix, CPA, to its Board of Directors and committees overseeing audit and financial policy, affirmed a US$0.53 quarterly dividend marking 100 years and 403 consecutive quarters of payouts, and initiated a major virtual power purchase agreement with ENGIE’s Big Sampson Wind Project. Together, these moves highlight Sonoco’s emphasis on experienced financial oversight, long-running cash returns to...
NYSE:UHS
NYSE:UHSHealthcare

A Look At Universal Health Services (UHS) Valuation After Recent Share Price Momentum

Why Universal Health Services is on investors’ radar today Universal Health Services (UHS) has drawn fresh attention after a period of solid recent returns, with the stock up 0.3% over the past day and 7.4% over the past week. That short term move comes alongside gains of 17.5% over the past month and 3.7% over the past 3 months. These moves are prompting investors to look more closely at what they are paying for the company’s earnings and cash flows. See our latest analysis for Universal...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Unveils AI Assistant And Sales Training As Shares Trade Below Targets

TriNet Group (NYSE:TNET) has introduced an AI-powered TriNet Assistant to support clients with HR tasks. The company is also expanding its TriNet Ascend sales training program into additional U.S. regions. These moves represent new product and talent development efforts beyond routine financial updates. TriNet Group comes into this news with a share price of $39.82 and a value score of 5, alongside multi year share price pressure. The stock has seen a 28.8% decline over the past week, 36.5%...